Compare BBNX & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | IBTA |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 604.2M |
| IPO Year | N/A | 2024 |
| Metric | BBNX | IBTA |
|---|---|---|
| Price | $10.37 | $22.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | $26.22 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 1.1M | 348.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $342,389,000.00 |
| Revenue This Year | $34.99 | $1.09 |
| Revenue Next Year | $34.47 | $10.15 |
| P/E Ratio | ★ N/A | $192.17 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.89 | $19.10 |
| 52 Week High | $32.71 | $56.60 |
| Indicator | BBNX | IBTA |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 51.38 |
| Support Level | N/A | $21.10 |
| Resistance Level | $15.53 | $28.32 |
| Average True Range (ATR) | 0.67 | 1.68 |
| MACD | 0.08 | -0.09 |
| Stochastic Oscillator | 11.22 | 31.04 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).